1. Second cancer risk and other late adverse effects of cancer therapy

   Newsletter Article 27 January 2013 Pages: 1 - 1

2. SADRAC reports on felodipine

   Newsletter Article 27 January 2013 Pages: 1 - 1

3. Lofepramine toxicity - an overview

   Newsletter Article 27 January 2013 Pages: 2 - 2

4. Safety of parenteral therapy with third generation cephalosporins

   Newsletter Article 27 January 2013 Pages: 3 - 4

5. Anabolic steroids

   Newsletter Article 27 January 2013 Pages: 4 - 5

6. Anoretics

   Newsletter Article 27 January 2013 Pages: 5 - 5

7. Baclofen overdose

   Newsletter Article 27 January 2013 Pages: 5 - 5

8. Beta lactams

   Newsletter Article 27 January 2013 Pages: 5 - 5

9. Captopril

   Newsletter Article 27 January 2013 Pages: 5 - 5

10. Cefoxitin

    Newsletter Article 27 January 2013 Pages: 5 - 6

11. Cisplatin see Epirubicin/cisplatin

    Newsletter Article 27 January 2013 Pages: 6 - 6

12. Cyclosporin

    Newsletter Article 27 January 2013 Pages: 6 - 6

13. Cyproterone

    Newsletter Article 27 January 2013 Pages: 6 - 6

14. Dapsone

    Newsletter Article 27 January 2013 Pages: 6 - 6

15. Deferoxamine

    Newsletter Article 27 January 2013 Pages: 6 - 6

16. Diphenylcyclopropenone

    Newsletter Article 27 January 2013 Pages: 6 - 6

17. Epirubicin/cisplatin

    Newsletter Article 27 January 2013 Pages: 6 - 6

18. Fentanyl

    Newsletter Article 27 January 2013 Pages: 6 - 7

19. Foscarnet

    Newsletter Article 27 January 2013 Pages: 7 - 7

20. General anaesthestics

    Newsletter Article 27 January 2013 Pages: 7 - 7

21. Gliclazide interaction

    Newsletter Article 27 January 2013 Pages: 7 - 7

22. Ibuprofen

    Newsletter Article 27 January 2013 Pages: 7 - 7

23. Ibuprofen see Indomethacin/ibuprofen

    Newsletter Article 27 January 2013 Pages: 7 - 7

24. Indeloxazine

    Newsletter Article 27 January 2013 Pages: 7 - 8

25. Indomethacin/ibuprofen

    Newsletter Article 27 January 2013 Pages: 8 - 8

26. Interferon alpha

    Newsletter Article 27 January 2013 Pages: 8 - 8

27. Isoflurane

    Newsletter Article 27 January 2013 Pages: 8 - 8

28. Isotretinoin

    Newsletter Article 27 January 2013 Pages: 8 - 9

29. Lidocaine

    Newsletter Article 27 January 2013 Pages: 9 - 9

30. Lithium

    Newsletter Article 27 January 2013 Pages: 9 - 9

31. Lithium interaction

    Newsletter Article 27 January 2013 Pages: 9 - 9

32. Metaraminol

    Newsletter Article 27 January 2013 Pages: 9 - 9

33. Naproxen

    Newsletter Article 27 January 2013 Pages: 9 - 9

34. Nicardipine see Propranolol interaction

    Newsletter Article 27 January 2013 Pages: 9 - 9

35. Oral contraceptives

    Newsletter Article 27 January 2013 Pages: 9 - 9

36. Papaverine

    Newsletter Article 27 January 2013 Pages: 9 - 10

37. Pentamidine

    Newsletter Article 27 January 2013 Pages: 10 - 10

38. Perphenazine

    Newsletter Article 27 January 2013 Pages: 10 - 10

39. Phenelzine

    Newsletter Article 27 January 2013 Pages: 10 - 10

40. Phenylbutazone see Lithium interaction

    Newsletter Article 27 January 2013 Pages: 10 - 10

41. Phenytoin

    Newsletter Article 27 January 2013 Pages: 10 - 10

42. Prazosin

    Newsletter Article 27 January 2013 Pages: 10 - 10

43. Propranolol interaction

    Newsletter Article 27 January 2013 Pages: 10 - 10

44. Pseudoephedrine overdose

    Newsletter Article 27 January 2013 Pages: 10 - 11

45. Pseudoephedrine poisoning

    Newsletter Article 27 January 2013 Pages: 11 - 11

46. Quinidine

    Newsletter Article 27 January 2013 Pages: 11 - 11

47. Quinine

    Newsletter Article 27 January 2013 Pages: 11 - 11

48. Quinine see Gliclazide interaction

    Newsletter Article 27 January 2013 Pages: 11 - 11

49. Salbutamol

    Newsletter Article 27 January 2013 Pages: 11 - 11

50. Thioridazine withdrawal

    Newsletter Article 27 January 2013 Pages: 11 - 12